HTA AND OFF-LABEL USE

Track:
HTA/Sustainability of Health Systems in Europe

Day & Time:
March 6, 4:00PM - 5:30PM

Session Number:
0108

Room Number:
Emerald Room

Type:
Session

Title:
HTA AND OFF-LABEL USE

Chair(s):
Lidia Retkowska-Mika, LLM
Director Legal DPT
Office for Registration of Med. Products, Poland

Description:
HTA AND OFF-LABEL USE

Presentation(s) & Speaker(s):
Legal Constraints on Off-Label use and HTA and Reimbursement Decisions
Peter W.L. Bogaert, MA
Partner
Covington & Burling LLP, Belgium

Off-Label Use of Medicinal Products- a solution for the healthcare system or escape from cost for Marketing Authorisation Holder?
Anna Maria Cieslik, DrMed,MPharm
Office For Registration of Medicinal Products, Poland

The “Incurable” Patients’ Perspective
David Head, MBA
Chief Executive
RP Fighting Blindness, United Kingdom